Has David Cashen, MD received payments from drug or device companies?

Yes. Drug and device makers reported $49,921 in general payments to David Cashen, MD across 73 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean David Cashen, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about David Cashen, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

David Cashen, MD

Orthopaedic Surgery · Bradenton, FLNPI 1124035696

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $46,225 of the $49,921 with a category attached, or 92.6%. UOC USA Inc accounts for 75.9% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2023 at $18,001 and has fallen 98.0% since, to $363 in 2025.

$49,921in general payments, 2019–2025

Across 73 payments — averaging $683.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

UOC USA Inc$38K
Maxx Orthopedics, Inc.$9K
Smith+Nephew$2K
Stryker$1K
Ferring Pharmaceuticals Inc.$216
Heron Therapeutics, Inc.$85
plus $438 from 13 others

$87,009in research payments, 2019–2025

Across 11 payments — averaging $7909.90 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Novartis$77K
Maxx Orthopedics, Inc.$7K
Medical Device Business Services, Inc.$3K

What the payments were for

Consulting fees$46,22593%
Travel & lodging$1,0802%
Food & beverage$2,6165%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
UOC USA Inc	10	$37,875
Maxx Orthopedics, Inc.	7	$8,555
Smith+Nephew	7	$1,630
Stryker	19	$1,122
Ferring Pharmaceuticals Inc.	9	$216
Heron Therapeutics, Inc.	1	$85
Arthrex	1	$81
Zimmer Biomet	2	$77
MVP Orthopedics Inc	2	$59
Boston Scientific	2	$35
Heraeus Medical, LLC.	4	$33
Molnlycke Health Care US, LLC	2	$31
Innovation Technologies Inc	1	$24
Siemens Medical Solutions USA, Inc.	1	$20
Bioventus LLC	1	$17
Think Surgical, Inc.	1	$17
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	1	$16
Pacira Therapeutics, Inc.	1	$15
Conformis, Inc.	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$49,921 in reported general payments places this provider in the 80th percentile of 1,263 orthopaedic surgery providers in Florida.

See all orthopaedic surgery providers in Florida →

Medicare billing

Part B allowed, 2024

$577,036

Medicare patients

990

Services billed

5,669

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Celecoxib	127	$3,425
Ondansetron OdtOndansetron	237	$1,248
Mupirocin	170	$928
Diclofenac Sodium	14	$799
Cefadroxil	79	$610
Amoxicillin	191	$339
Meloxicam	88	$199
Tramadol Hcl	57	$189
Methylprednisolone	15	$66
Oxycodone Hcl	14	$60
Clindamycin Hcl	16	$56

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Bradenton

Alan ValadieBradenton$415K
Andrew CooperClearwater$102M
Richard HynesMelbourne$34.8M
Mark FrankleTemple Terrace$31M
Roy SandersTemple Terrace$19.6M
George HaidukewychOrlando$10M
Robert SantrockFernandina Beach$7.3M
Martin RocheFt. Lauderdale$7.1M
Steven LyonsTampa$6.7M
Thomas BernasekTemple Terrace$6.4M

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →